A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps

Proton pump inhibitors (PPIs) are commonly used medications to treat acid-related conditions, including gastro-esophageal reflux disease (GERD). Gastroenterology guidelines mention the importance of CYP2C19 in PPI metabolism and the influence of CYP2C19 genetic variations on variable responses to PP...

Descripción completa

Detalles Bibliográficos
Autores principales: Eken, Eda, Estores, David S, Cicali, Emily J, Wiisanen, Kristin K, Johnson, Julie A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296543/
https://www.ncbi.nlm.nih.gov/pubmed/37383676
http://dx.doi.org/10.2147/PGPM.S371994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296543/
https://www.ncbi.nlm.nih.gov/pubmed/37383676
http://dx.doi.org/10.2147/PGPM.S371994

Ejemplares similares